| Date | Title | Description | Source |
| 28.06.2023 | Phaxiam Therapeutics annonce son nouveau code mnémonique sur... | /EIN News/ -- Phaxiam Therapeutics annonce son nouveau code mnémonique
sur Euronext et Nasdaq : PHXM... | einpresswi... |
| 28.06.2023 | Phaxiam Therapeutics announces its new mnemonic code on Euro... | /EIN News/ -- Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM
Lyo... | einpresswi... |
| 23.06.2023 | ERYTECH announces the approval of the merger with Pherecydes... | /EIN News/ --
ERYTECH announces the approval of the merger with Pherecydes and reports th... | einpresswi... |
| 23.06.2023 | ERYTECH annonce l'approbation de la fusion avec Pherecydes e... | /EIN News/ --
ERYTECH annonce l'approbation de la fusion avec Pherecydes et communique le... | einpresswi... |
| 12.06.2023 | ERYTECH répond à la désinformation d’Akkadian | /EIN News/ -- COMMUNIQUÉ DE PRESSE
ERYTECH répond à la désinformation d’Akkadian
La contes... | einpresswi... |
| 12.06.2023 | ERYTECH Responds to Akkadian’s Disinformation | /EIN News/ -- ERYTECH Responds to Akkadian’s Disinformation
Akkadian’s challenge of the mer... | einpresswi... |
| 15.05.2023 | ERYTECH Provides Update on the Announced Combination with PH... | /EIN News/ -- ERYTECH Provides Update on the Announced Combination with PHERECYDES
Entry in... | einpresswi... |
| 15.05.2023 | Point d'étape sur le rapprochement entre ERYTECH et PHERECYD... | /EIN News/ -- Point d'étape sur le rapprochement
entre ERYTECH et PHERECYDES
Conclusion du ... | einpresswi... |
| 17.04.2023 | ERYTECH Announces Approval to Transfer its Listing to the Na... | /EIN News/ -- ERYTECH Announces Approval to Transfer its Listing
to the Nasdaq Capital Market
Camb... | einpresswi... |
| 17.04.2023 | ERYTECH annonce l'approbation du transfert de sa cotation ve... | /EIN News/ -- ERYTECH annonce l'approbation du transfert de sa cotation vers le Nasdaq Capital Marke... | einpresswi... |
| 22.03.2023 | ERYTECH Provides Business and Financial Update for the Fourt... | /EIN News/ -- ERYTECH Provides Business and Financial Update
for the Fourth Quarter and Full Year 20... | einpresswi... |
| 22.03.2023 | ERYTECH fait le point sur ses activités et publie ses résult... | /EIN News/ -- ERYTECH fait le point sur ses activités et publie ses résultats du quatrième trimestre... | einpresswi... |
| 13.10.2022 | ERYTECH Announces Receipt of Nasdaq Notice | ERYTECH Announces Receipt of Nasdaq Notice
Cambridge, MA (U.S.) and Lyon (France), October 13, 2022... | einpresswi... |
| 13.10.2022 | ERYTECH Announces Receipt of Nasdaq Notice | ERYTECH Announces Receipt of Nasdaq Notice
Cambridge, MA (U.S.) and Lyon (France), October 13, 2022... | globenewsw... |
| 13.10.2022 | ERYTECH Announces Receipt of Nasdaq Notice | /EIN News/ -- ERYTECH Announces Receipt of Nasdaq Notice
Cambridge, MA (U.S.) and Lyon (France), Oc... | einpresswi... |
| 13.10.2022 | ERYTECH reçoit une notification du Nasdaq | /EIN News/ -- ERYTECH reçoit une notification du Nasdaq
Lyon (France) et Cambridge, MA (U.S), le 13... | einpresswi... |
| 12.09.2022 | ERYTECH Provides Business and Financial Update for the First... | ERYTECH Provides Business and Financial Update
for the First Half of 2022
Conference call and webca... | globenewsw... |
| 24.08.2022 | ERYTECH Provides Regulatory Update | ERYTECH Provides Regulatory Update
ERYTECH to stop further plans to pursue a BLA submission seeking... | globenewsw... |
| 24.06.2022 | Report – ERYTECH’s Combined Shareholders’ Meeting On June 24... | REPORT – ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022
Cambridge, MA (U.S.) and Lyon (F... | globenewsw... |
| 24.05.2022 | ERYTECH Announces the Availability of the Documents for its ... | ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on Jun... | globenewsw... |
| 17.05.2022 | ERYTECH to Present at the H.C. Wainwright Global Investment ... | ERYTECH to Present at the
H.C. Wainwright Global Investment Conference
Cambridge, MA (U.S.) and Lyo... | globenewsw... |
| 12.05.2022 | ERYTECH Provides Business and Financial Update for the First... | ERYTECH Provides Business and Financial Update
for the First Quarter of 2022
Conference call and we... | globenewsw... |
| 28.04.2022 | ERYTECH Announces Filing of 2021 Universal Registration Docu... | ERYTECH Announces Filing of
2021 Universal Registration Document and
2021 Annual Report on Form 20-F... | globenewsw... |
| 25.04.2022 | ERYTECH Sells U.S. Manufacturing Facility and Enters Long-Te... | ERYTECH Sells U.S. Manufacturing Facility and Enters Long-Term Supply Agreement with Catalent Catale... | globenewsw... |
| 06.04.2022 | ERYTECH Announces Publication of Positive Results from Eryas... | ERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL... | globenewsw... |
| 04.04.2022 | ERYTECH to Present Novel Vesiculation Approach at the 24th M... | ERYTECH to Present Novel Vesiculation Approach
at the 24th Meeting of the European Red Cell Society ... | globenewsw... |
| 28.03.2022 | ERYTECH to Participate in the Upcoming April Investor Confer... | ERYTECH to Participate in
the Upcoming April Investor Conferences
Cambridge, MA (U.S.) and Lyon (Fr... | globenewsw... |
| 11.03.2022 | ERYTECH Provides Business and Financial Update for the Fourt... | ERYTECH Provides Business and Financial Update
for the Fourth Quarter and Full Year 2021
Conference... | globenewsw... |
| 08.02.2022 | ERYTECH Expands Patent Portfolio for the Treatment of Rare M... | ERYTECH Expands Patent Portfolio
for the Treatment of Rare Metabolic Diseases
Cambridge, MA (U.S.) ... | globenewsw... |
| 24.01.2022 | ERYTECH Announces Presentation of Results of Two Clinical Tr... | ERYTECH Announces Presentation of
Results of Two Clinical Trials of Eryaspase
in Pancreatic Cancer a... | globenewsw... |
| 03.01.2022 | ERYTECH to Participate in the Upcoming January Virtual Inves... | ERYTECH to Participate in
the Upcoming January Virtual Investor Conferences
Cambridge, MA (U.S.) an... | globenewsw... |
| 15.12.2021 | ERYTECH ANNOUNCES $7.85 MILLION REGISTERED DIRECT OFFERING | Lyon - ERYTECH Pharma (Nasdaq & Euronext: ERYP) (the 'Company'), a clinical-stage biopharmaceuti... | marketscre... |
| 14.12.2021 | ERYTECH Announces $7.85 Million Registered Direct Offering | ERYTECH Announces $7.85 Million
Registered Direct Offering
Lyon (France) and Cambridge, MA (U.S.), ... | globenewsw... |
| 13.12.2021 | ERYTECH Announces Presentation of Results of Expanded Access... | ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeti... | globenewsw... |
| 29.11.2021 | ERYTECH Secures US Patent Directed to Sequential Use of Meth... | ERYTECH Secures US Patent Directed to Sequential Use of Methioninase & Asparaginase against Soli... | globenewsw... |
| 15.11.2021 | ERYTECH Provides Business and Financial Update for the Third... | ERYTECH Provides Business and Financial Update
for the Third Quarter of 2021
Conference call and we... | globenewsw... |
| 15.11.2021 | ERYTECH Announces Upcoming Poster Presentation at the 2021 A... | ERYTECH Announces Upcoming Poster Presentation at the 2021 American Society of Hematology Annual Mee... | marketscre... |
| 15.11.2021 | ERYTECH Announces Upcoming Poster Presentation at the 2021 A... | ERYTECH Announces Upcoming Poster Presentation at the 2021 American Society of Hematology Annual Mee... | globenewsw... |
| 10.11.2021 | ERYTECH Announces Publication of a Paper on Red-Blood Cell C... | ERYTECH Announces Publication of a Paper
on Red-Blood Cell Characterization
in High Impact Peer Revi... | marketscre... |
| 10.11.2021 | ERYTECH Announces Publication of a Paper on Red-Blood Cell C... | ERYTECH Announces Publication of a Paper
on Red-Blood Cell Characterization
in High Impact Peer Revi... | globenewsw... |
| 09.11.2021 | ERYTECH to Present at the 12th Annual Jefferies Global Londo... | ERYTECH to Present at the 12th Annual Jefferies Global London Healthcare Conference
In-Person Dates:... | globenewsw... |
| 25.10.2021 | ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Er... | ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Adv... | globenewsw... |
| 04.10.2021 | ERYTECH Announces Maximum Tolerated Dose Declared in a Phase... | ERYTECH Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator Sponsored Trial of
Eryas... | globenewsw... |
| 29.07.2021 | ERYTECH Pharma S A : Granted U.S. FDA Fast Track Designation... | ERYTECH Granted U.S. FDA Fast Track Designation
for Eryaspase in Hypersensitive ALL
Fast Track desig... | marketscre... |
| 29.04.2021 | ERYTECH Announces $30.0 Million Registered Direct Offering | ERYTECH Announces $30.0 Million
Registered Direct Offering
Lyon (France) and Cambridge, MA (U.S.), ... | marketscre... |
| 10.02.2021 | ERYTECH to Present at the 2021 BIO CEO & Investor Confer... | ERYTECH to Present at the 2021 BIO CEO &
Investor Conference
Lyon (France) and Cambridge, MA (... | globenewsw... |
| 10.11.2017 | Term Sheet — Friday, November 10 | HOT TAKES
Happy Friday, Term Sheet readers.
Paid Content Securing the enterprise without boundarie... | fortune.co... |
| 07.11.2017 | Term Sheet — Tuesday, November 7 | THE LITTLE PINK PILL
Good morning, Term Sheet readers.
Paid Content You can't secure what you can'... | fortune.co... |
| 09.10.2017 | Erytech seeks $100M IPO for pivotal tumor starvation trial | Erytech Pharma has filed to raise up to $100 million (€85 million) in a Nasdaq IPO to fund a phase 3... | fiercebiot... |
| 09.10.2017 | Term Sheet — Monday, October 9 | HITTING THE BRAKES
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without ... | fortune.co... |
| 12.09.2017 | Erytech mulls first-line use for pivotal pancreatic cancer t... | Erytech is preparing to move eryaspase into a pivotal trial after full data (PDF) from a phase 2b af... | fiercebiot... |
| 09.12.2015 | Erytech raises €25M to broaden cancer pipeline ahead of poss... | Erytech (EPA:ERYP) has raised €25.4 million ($27.4 million) from institutional investors in the U.S.... | fiercebiot... |
